Log in or Sign up for Free to view tailored content for your specialty!
Spondyloarthropathies News
FDA approves Cyltezo as first interchangeable biosimilar for inflammatory disease
The FDA has designated Cyltezo the first approved interchangeable biosimilar to treat certain inflammatory diseases, allowing pharmacists to substitute it for Humira without the need for the prescriber to alter the prescription.
Healio launches rheumatology quiz platform, Rheum + Boards
Healio announced the launch of Rheum and Boards, a quiz-based, online learning resource for rheumatologists, according to a Healio press release.
Log in or Sign up for Free to view tailored content for your specialty!
Upadacitinib improves signs, symptoms of ankylosing spondylitis, nonradiographic axSpA
Upadacitinib significantly reduced signs and symptoms of both ankylosing spondylitis and nonradiographic axial spondyloarthritis, as well as improved physical function and disease activity, according to a pair of phase 3 studies from AbbVie.
PREVENT: Secukinumab improves non-radiographic axial SpA symptoms across sexes, subgroups
Secukinumab improves non-radiographic axial spondyloarthritis signs and symptoms across patients grouped by C-reactive protein level, MRI score, HLA-B27 status and sex, according to data published in Arthritis Research & Therapy.
Ankylosing spondylitis incidence similar among men, women in study of US Army veterans
In contrast to some previous studies, an analysis of U.S. Army personnel found that the incidence of ankylosing spondylitis was similar between men and women, according to data published in Arthritis Care & Research.
Live varicella-zoster vaccine effective, 'can be safely used' with TNF inhibitors
The live attenuated varicella-zoster vaccine is safe and provides “reasonable short-term” effectiveness in patients receiving TNF inhibitors for a variety of indications, according to data published in the Annals of Internal Medicine.
COVID-19 testing 20% higher among patients with immune-mediated inflammatory disease
Patients with immune mediated inflammatory diseases are tested for COVID-19 at a 20% higher rate than the general population, according to data published in Arthritis Care & Research.
'Tips and tricks' for improving diagnosis, treatment of musculoskeletal disease
A reminder of some common and not-so-common clinical scenarios can make every rheumatologist more capable of delivering optimal patient care, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.
Single pain management skills class shows 'meaningful reductions' in lower back pain
A single-session class on pain management skills was noninferior to 8-week cognitive behavioral therapy, and superior to a health education class, for pain catastrophizing in patients with chronic lower back pain, according to data.
Inflammatory arthritis diagnosis prior to age 30 years 'impairs' male fertility
Male patients diagnosed with inflammatory arthritis at or before peak reproductive age have a lower fertility rate, a higher childlessness rate, and more fertility issues, according to data published in the Annals of the Rheumatic Diseases.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read